Predictive toxicology in drug development

Area of Science:

• Computational toxicology and cheminformatics in drug discovery.
• Application of predictive modeling in pharmaceutical development.

Background:

• High attrition rates in late-stage clinical trials (Phase II onwards) represent a significant cost and time burden in drug development.
• Current methods often fail to identify toxicological problems in new chemical entities (NCEs) early enough, leading to expensive late-stage terminations.

Framework:

• Development and assessment of in silico modeling and expert systems for early-stage drug evaluation.
• Focus on predictive models for evaluating chemical libraries during the design phase.

Implementation:

• Utilizing predictive models to assess potential toxic effects during the lead optimization stage of chemical projects.
• Leveraging computational tools to screen chemical libraries for safety and efficacy.

Implications:

• Potential to reduce the number of NCEs progressing to clinical development by identifying issues earlier.
• Significant cost savings and shortened drug development timelines by mitigating late-stage failures.
• Advancement of in silico methods as a critical component of modern drug discovery pipelines.